SOUTH KOREA · OPENDART
SeouLinBioscienceCO.,LTD.
서린바이오 · 038070 · KOSDAQ · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insiders' buying price vs the latest close
Insiders paid 6,330.00 KRW a share on average (1 purchase line, 1 buyer, 2026-01-30 – 2026-01-30). The close on 2026-10-16 was 39.8% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-30 | Kang Mi Ok | CEO | Bought on the exchange | 2,300 | ₩6,330 | ₩14.6M | DART ↗ |
Other changes in holdings · 6
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-03-26 | Ahn Kwang-Ki | Auditor | Stock dividend(+) | 49 | DART ↗ |
| 2026-03-26 | Kang Mi Ok | CEO | Stock dividend(+) | 203 | DART ↗ |
| 2026-03-26 | Hwang Eul-Moon | CEO | Stock dividend(+) | 57,737 | DART ↗ |
| 2025-03-26 | Ahn Kwang-Ki | Auditor | Stock dividend(+) | 49 | DART ↗ |
| 2025-03-26 | Kang Mi Ok | CEO | Stock dividend(+) | 203 | DART ↗ |
| 2025-03-26 | Hwang Eul-Moon | CEO | Stock dividend(+) | 57,676 | DART ↗ |